COST Action CA18218

Launch of the GBD 2019 study results

The GBD study offers a powerful resource to understand the changing health challenges facing people across the world in the 21st century. Led by the Institute for Health Metrics and Evaluation (IHME), the GBD study is the most comprehensive worldwide observational epidemiological study to date. By tracking progress within and between countries GBD provides an important tool to inform clinicians, researchers, and policy makers, promote accountability, and improve lives worldwide.

Published in October 2020, The Lancet’s special issue on GBD includes the most up-to-date global health data from 2019 with the latest analysis focused on five key themes: demographics, diseases and injuries, risk factors, population forecasting, and universal health coverage. Further information is also available via The Lancet's GBD Resource Centre.

To explore the new GBD 2019 results, please consult the GBD Compare Tool and the GBD Results Tool.

About COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. COST Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. Read more via

Get in touch

COST logo

Funded by the European Union

Website by  woluweb mini